Almost as soon as TiGenix gained the European regulator’s recommendation for its allogeneic adipose-derived mesenchymal stem cell (MSC) therapy to treat complex perianal fistulas in Crohn’s disease, its partner Takeda moved to strike a deal. On December 15 the European Medicines Agency (EMA)… Para acessar a publicação na íntegra clique aqui Fonte: 212 VOLUME 36 NUMBER 3 MARCH 2018 NATURE BIOTECHNOLOGY…
Migraine drug race turns its final corner, FDA decisions in sight
Over the next six months, the US Food and Drug Administration (FDA) is widely anticipated to approve a trio of monoclonal antibody (mAb) drugs for preventing migraine, in what could be a new era in the disease’s treatment… Para acessar a publicação na íntegra clique aqui Fonte: NATURE BIOTECHNOLOGY VOLUME 36 NUMBER 3 MARCH 2018 207…
The market for chimeric antigen receptor T cell therapies
2017 was a landmark year in oncology. The FDA approved the first two CD19-targeted chimeric antigen receptor (CAR) T cell therapies: tisagenlecleucel-T (Kymriah; Novartis) and axicabtagene ciloleucel (Yescarta; Kite Pharma/Gilead Sciences). These therapies have remarkable efficacy in some blood cancers and herald a paradigm shift in oncology treatment… Para acessar a publicação na íntegra clique aqui NATURE REVIEWS | DRUG DISCOVERY VOLUME 17 | MARCH 2018 | 161…
Alnylam prepares to land first RNAi drug approval
Drug developers have been fishing in the bumpy RNA interference (RNAi) waters for years without a catch in sight. They probably won’t have to wait much longer. In December 2017, RNAi pioneer Alnylam Pharmaceuticals… Para acessar a publicação na íntegra clique aqui Click here to original publication. Fonte: 156 | MARCH 2018 | VOLUME 17 www.nature.com/nrd…
Secretário geral do Ministério da Ciência, Tecnologia, Inovações e Comunicações e diretor financeiro da FINEP visitaram o CIEnP.
No dia 8 de março de 2018, o CIEnP recebeu as visitas do Dr. Elton Zacarias Secretário Geral do MCTIC e do Diretor Financeiro da FINEP Dr. Ronaldo Camargo. O Diretor presidente do CIEnP Prof. Joao B. Calixto fez uma explanação geral a respeito da criação do CIEnP desde o momento que recebeu a encomenda por parte do MCTIC e do MS para a criação do Centro em 2008, sobre a edificação do Centro e seu funcionamento que se iniciou…